Search

everythinglearnresearchcommunity

for

Search:↓

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Lichen planus may be associated with a higher risk of metabolic syndrome.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hirsutism in young girls can have causes other than PCOS, so diagnoses should be reassessed if treatments don't work.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

More research is needed to understand how testosterone is maintained in adult males.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Women with PCOS have more emotional and body image issues than healthy women.